• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据博洛尼亚标准,卵巢反应不良的女性进行自然周期 IVF 的活产率。

Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.

机构信息

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

出版信息

Hum Reprod. 2012 Dec;27(12):3481-6. doi: 10.1093/humrep/des318. Epub 2012 Aug 30.

DOI:10.1093/humrep/des318
PMID:22940767
Abstract

STUDY QUESTION

What is the effect of natural cycle IVF in women with poor ovarian response according to the new ESHRE definition for poor ovarian responders: the Bologna criteria?

SUMMARY ANSWER

Although natural cycle IVF is a promising treatment option for normal responders, poor ovarian responders, as described by the Bologna criteria, have a very poor prognosis and do not appear to experience substantial benefits with natural cycle IVF.

WHAT IS KNOWN ALREADY

Previous trials have shown that natural cycle IVF is an effective treatment for the general infertile population and might be an option for poor ovarian responders. However, none of the trials have examined the effect of natural cycle IVF in poor responders according to the Bologna criteria, the newly introduced definition by the ESHRE Working Group on Poor Ovarian Response Definition. In this trial, we examined the effect of natural cycle IVF in poor ovarian responders fulfilling the Bologna criteria.

STUDY DESIGN, SIZE, DURATION: In this retrospective cohort trial, 164 consecutive patients, undergoing 469 natural cycle IVFs between 2008 and 2011 were included. Patients were stratified as poor and normal responders: 136 (390 cycles) were poor ovarian responders according to the Bologna criteria, whereas 28 women (79 treatment cycles) did not fulfil the criteria and were considered as normal responders.

PARTICIPANTS/MATERIALS, SETTING, METHODS: All patients were monitored with hormonal analysis and ultrasound scan every second day, from Day 7 or 8 of the cycle onwards. When a follicle of >16 mm was observed, ovulation was triggered with 5000 IU of i.m. hCG and oocyte retrieval was performed 32 h later.

MAIN RESULTS AND THE ROLE OF CHANCE

Live birth rates in poor responders according to the Bologna criteria were significantly lower compared with the control group of women; the live birth rate per cycle was 2.6 versus 8.9%, P = 0.006 and the live birth rate per treated patient was 7.4 versus 25%, P = 0.005. In poor responders according to the Bologna criteria, live birth rates were consistently low and did not differ among different age groups (≤ 35 years, 36-39 years and ≥ 40 years), with a range from 6.8 to 7.9%.

LIMITATIONS, REASONS FOR CAUTION: A limitation of our analysis is its retrospective design; however, taking into account that we included only consecutive patients treated with exactly the same protocol, the likelihood of selection bias might be considerably limited. In addition, the control group in our study refers to women of younger age and therefore the promising results among patients who did not fulfil the Bologna criteria apply only to women of younger age.

WIDER IMPLICATIONS OF THE FINDINGS

Our trial suggests that although natural cycle IVF is a promising treatment option for younger normal responders, its potential is very limited to poor ovarian responders as described by the Bologna criteria, irrespective of patient's age. This highlights the very poor prognosis of these women and therefore the urgent need for future trials to examine the effect of ovarian stimulation protocols in women with poor ovarian response as described by the Bologna criteria.

STUDY FUNDING/COMPETING INTEREST(S): No funding was used. There are no competing interests to declare.

摘要

研究问题

根据新的 ESHRE 卵巢反应不良定义(即博洛尼亚标准),对于卵巢反应不良的患者,自然周期 IVF 的效果如何?

总结答案

尽管自然周期 IVF 是正常反应者的一种有前途的治疗选择,但博洛尼亚标准定义的卵巢反应不良者的预后非常差,并且似乎不会从自然周期 IVF 中获得实质性益处。

已知情况

先前的试验表明,自然周期 IVF 是治疗一般不孕人群的有效方法,也可能是卵巢反应不良者的一种选择。然而,没有一项试验研究了根据博洛尼亚标准(即 ESHRE 卵巢反应不良定义工作组新引入的标准),在卵巢反应不良者中进行自然周期 IVF 的效果。在这项试验中,我们研究了在满足博洛尼亚标准的卵巢反应不良者中进行自然周期 IVF 的效果。

研究设计、大小和持续时间:在这项回顾性队列试验中,纳入了 2008 年至 2011 年间接受 469 次自然周期 IVF 的 164 例连续患者。患者分为卵巢反应不良者和正常反应者:136 例(390 个周期)根据博洛尼亚标准为卵巢反应不良者,而 28 例女性(79 个治疗周期)不符合标准,被认为是正常反应者。

参与者/材料、设置和方法:所有患者均接受激素分析和超声扫描监测,从周期第 7 或 8 天开始,每隔一天监测一次。当观察到 >16mm 的卵泡时,用 5000IU 的肌内 hCG 触发排卵,32 小时后进行卵母细胞采集。

主要结果和机会的作用

根据博洛尼亚标准,卵巢反应不良者的活产率明显低于对照组女性;每周期的活产率为 2.6%对 8.9%,P=0.006,每例治疗患者的活产率为 7.4%对 25%,P=0.005。在根据博洛尼亚标准的卵巢反应不良者中,活产率一直很低,并且在不同年龄组(≤35 岁、36-39 岁和≥40 岁)之间没有差异,范围为 6.8%至 7.9%。

局限性、谨慎的原因:我们分析的一个限制是其回顾性设计;然而,考虑到我们只纳入了接受完全相同方案治疗的连续患者,选择偏倚的可能性可能会大大降低。此外,我们研究中的对照组指的是年龄较小的女性,因此在不符合博洛尼亚标准的患者中,有希望的结果仅适用于年龄较小的女性。

研究结果的更广泛意义

我们的试验表明,尽管自然周期 IVF 是年轻正常反应者的一种有前途的治疗选择,但对于博洛尼亚标准定义的卵巢反应不良者,其潜力非常有限,无论患者的年龄如何。这突出了这些女性的预后非常差,因此迫切需要未来的试验来研究博洛尼亚标准定义的卵巢反应不良者的卵巢刺激方案的效果。

研究资金/利益冲突:未使用任何资金。没有利益冲突。

相似文献

1
Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.根据博洛尼亚标准,卵巢反应不良的女性进行自然周期 IVF 的活产率。
Hum Reprod. 2012 Dec;27(12):3481-6. doi: 10.1093/humrep/des318. Epub 2012 Aug 30.
2
Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.拮抗剂方案与高剂量促性腺激素刺激方案在卵巢低反应患者中应用的比较:改良自然周期与体外受精结局
Hum Reprod. 2015 Oct;30(10):2321-30. doi: 10.1093/humrep/dev198. Epub 2015 Aug 25.
3
Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.在拮抗剂处理的卵巢反应不良者中添加高纯度 HMG 后加用果纳芬:一项初步研究。
Hum Reprod. 2013 May;28(5):1254-60. doi: 10.1093/humrep/det045. Epub 2013 Feb 26.
4
A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria.根据博洛尼亚标准对反应不良者进行 IVF 的预后和成本效益的回顾性评估。
Hum Reprod. 2015 Feb;30(2):315-22. doi: 10.1093/humrep/deu319. Epub 2014 Nov 28.
5
Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.内异症囊肿剔除术后与特发性 DOR 患者行卵巢储备功能降低的手术治疗:体外受精结局的比较。
Hum Reprod. 2015 Apr;30(4):840-7. doi: 10.1093/humrep/dev029. Epub 2015 Mar 3.
6
Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.Corifollitropin alfa 序贯高纯度 HMG 与重组 FSH 在年轻卵巢低反应患者中的应用:一项多中心随机对照临床试验。
Hum Reprod. 2017 Nov 1;32(11):2225-2233. doi: 10.1093/humrep/dex296.
7
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?体外受精/卵胞浆内单精子注射的传统卵巢刺激和单胚胎移植。在利用所有新鲜和冷冻胚胎后,我们需要多少个卵母细胞才能使累积活产率最大化?
Hum Reprod. 2016 Feb;31(2):370-6. doi: 10.1093/humrep/dev316. Epub 2016 Jan 2.
8
Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.在博洛尼亚接受体外受精/卵胞浆内单精子注射卵巢刺激治疗的低反应者的活产率。
Reprod Biomed Online. 2014 Apr;28(4):469-74. doi: 10.1016/j.rbmo.2013.11.010. Epub 2013 Dec 4.
9
Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.改良自然周期与控制性卵巢过度刺激 IVF:三种模拟治疗方案的成本效益评估。
Hum Reprod. 2013 Dec;28(12):3236-46. doi: 10.1093/humrep/det386. Epub 2013 Oct 27.
10
Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?对于“真正”对控制性卵巢过度刺激反应不良的患者,修改后的自然体外受精周期是否合理?
Fertil Steril. 2014 Jun;101(6):1624-8. doi: 10.1016/j.fertnstert.2014.02.036. Epub 2014 Mar 26.

引用本文的文献

1
Cumulative live birth rates among over 13,000 poor ovarian responders from 2015 to 2023: a retrospective cohort study assessing the efficacy of natural cycle and controlled ovarian stimulation.2015年至2023年期间13000多名卵巢低反应患者的累积活产率:一项评估自然周期和控制性卵巢刺激疗效的回顾性队列研究
J Assist Reprod Genet. 2025 Jun 14. doi: 10.1007/s10815-025-03544-z.
2
Oocyte and zygote development potential in minimal stimulation, natural cycle and conventionally stimulated IVF: an international multi-centre retrospective cohort study.轻度刺激、自然周期及常规刺激体外受精中卵母细胞和受精卵的发育潜能:一项国际多中心回顾性队列研究
J Assist Reprod Genet. 2025 May 28. doi: 10.1007/s10815-025-03508-3.
3
Untargeted metabolomics reveals homogeneity and heterogeneity between physiological and pathological ovarian aging.
非靶向代谢组学揭示了生理性和病理性卵巢衰老之间的同质性和异质性。
J Ovarian Res. 2025 Mar 17;18(1):56. doi: 10.1186/s13048-025-01625-2.
4
Clinical effectiveness of spindle-view intracytoplasmic sperm injection compared to conventional intracytoplasmic sperm injection in patients with poor ovarian response and previous implantation failure.与传统卵胞浆内单精子注射相比,纺锤体观察法卵胞浆内单精子注射在卵巢反应不良及既往种植失败患者中的临床疗效。
Obstet Gynecol Sci. 2024 May;67(3):304-313. doi: 10.5468/ogs.23268. Epub 2024 Feb 16.
5
Utilization of Cryopreserved Oocytes in Patients With Poor Ovarian Response After Planned Oocyte Cryopreservation.计划冷冻卵子后卵巢反应不良患者的冻卵利用。
JAMA Netw Open. 2024 Jan 2;7(1):e2349722. doi: 10.1001/jamanetworkopen.2023.49722.
6
The effects of flexible short protocol with gonadotropin-releasing hormone antagonist on preventing premature ovulation in poor responders.拮抗剂方案对预防卵巢低反应患者早排卵的效果。
Arch Gynecol Obstet. 2024 Feb;309(2):689-697. doi: 10.1007/s00404-023-07287-z. Epub 2023 Dec 5.
7
TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis.TEAS、DHEA、CoQ10 和 GH 对接受 IVF-ET 的卵巢反应不良患者的影响:系统评价和网络荟萃分析。
Reprod Biol Endocrinol. 2023 Jul 18;21(1):64. doi: 10.1186/s12958-023-01119-0.
8
What should be the strategy in case of a big follicle at the start of the cycle? Shall we start the stimulation or postpone it to the next cycle?如果在月经周期开始时发现有一个大卵泡,应该采取什么策略?我们是开始促排卵还是推迟到下一个周期?
Turk J Obstet Gynecol. 2022 Dec 13;19(4):275-280. doi: 10.4274/tjod.galenos.2022.15943.
9
Preventing Growth Stagnation and Premature LH Surge Are the Keys to Obtaining a Viable Embryo in Monofollicular IVF Cycles: A Retrospective Cohort Study.预防生长停滞和过早促黄体生成素峰是单卵泡体外受精周期中获得可存活胚胎的关键:一项回顾性队列研究。
J Clin Med. 2022 Dec 1;11(23):7140. doi: 10.3390/jcm11237140.
10
Accumulated Vitrified Embryos Could Be a Method for Increasing Pregnancy Rates in Patients with Poor Ovarian Response.累积玻璃化冷冻胚胎可能是提高卵巢反应不良患者妊娠率的一种方法。
J Clin Med. 2022 Aug 23;11(17):4940. doi: 10.3390/jcm11174940.